GLENMARK PHARMS LTD FDA Approval ANDA 213235

ANDA 213235

GLENMARK PHARMS LTD

FDA Drug Application

Application #213235

Application Sponsors

ANDA 213235GLENMARK PHARMS LTD

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2020-11-30STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

GLENMARK PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213235
            [companyName] => GLENMARK PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"AXITINIB","activeIngredients":"AXITINIB","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/30\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-11-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.